We are excited to officially share that Mike Payne, a leader in digital health, has joined as Mymee's newest advisor. This supports the recently announced expanded commercialization of Mymee’s digital care program aimed at getting this innovative program into the hands of autoimmune patients across the country to help them reclaim their health.
Mike brings tremendous experience, ideal to help guide Mymee in this next stage. Mike is an innovator in commercialization of evidence-based, digitally-empowered health interventions. He gained this experience while working at leading companies including Omada Health, Virta Health, and Zoom+Care. His professional experience also includes the biotechnology & pharmaceutical industry while working at McKinsey and Gilead Sciences.
"The addition of an industry expert like Mike to our advisory board will accelerate Mymee’s commercialization and improve the quality of life of people living with autoimmune disease” said Mette Dyhrberg, Mymee’s Founder and CEO. “His insights and perspectives are invaluable as we continue to scale. We are delighted to have someone with his experience join the team.”
This appointment comes at an important time in Mymee’s development, following the recent announcement of Melinda Decker as Mymee’s Chief Commercial Officer. It also comes at a critical time for people living with autoimmune disease. The COVID-19 pandemic has highlighted the prevalence of autoimmunity and immune-compromised people in our communities. It is one of the costliest disease categories in US healthcare and unfortunately growing rapidly. Not only is the prevalence increasing, but the total cost for treatment is, as well.
“Mymee takes a diametrically different approach to treating autoimmunity,” Dyhrberg continued. “We use symptoms to crack the code. By identifying the root cause of these chronic disease symptoms and removing triggers through behavior modification, the Mymee program enables the immune system to stop attacking itself. It’s an innovative personalized intervention that improves health outcomes.”
More About Mymee
Mymee, Inc. is a digital health company that empowers those who suffer from autoimmune disease, like Lupus, Rheumatoid Arthritis, and Crohn’s, to reclaim their health. Mymee’s program takes a highly personalized approach that uses proven technology to decode each individual’s unique triggers. The Mymee program combines an intuitive mobile app, data analytics, and certified health coaches to identify triggers for disease symptoms, including diet and environmental factors, to improve health. The certified health coaches help guide behaviors and assist individuals to master their autoimmunity.
Mymee has demonstrated clinically meaningful improvement in fatigue, pain, and other quality-of-life measures. Mymee currently offers it’s program directly to individuals, as well as to large self-insured employers and health plans.
As background, autoimmune diseases include Rheumatoid Arthritis (RA), Lupus (SLE), Psoriasis,, Psoriatic Arthritis (PsA), Crohn’s, Multiple Sclerosis (MS), Inflammatory Bowel Disease (IBD), Ankylosing Spondylitis (AS), and approximately 80 more.
To speak to an enrollment specialist about starting the Mymee program, schedule a call.
